Literature DB >> 28874444

Modulation of CD4+ and CD8+ T Cell Function and Cytokine Responses in Strongyloides stercoralis Infection by Interleukin-27 (IL-27) and IL-37.

Rajamanickam Anuradha1, Saravanan Munisankar1, Yukthi Bhootra1, Chandrakumar Dolla2, Paul Kumaran2, Thomas B Nutman3, Subash Babu4,3.   

Abstract

Strongyloides stercoralis infection is associated with diminished antigen-specific Th1- and Th17-associated responses and enhanced Th2-associated responses. Interleukin-27 (IL-27) and IL-37 are two known anti-inflammatory cytokines that are highly expressed in S. stercoralis infection. We therefore wanted to examine the role of IL-27 and IL-37 in regulating CD4+ and CD8+ T cell responses in S. stercoralis infection. To this end, we examined the frequency of Th1/Tc1, Th2/Tc2, Th9/Tc9, Th17/Tc17, and Th22/Tc22 cells in 15 S. stercoralis-infected individuals and 10 uninfected individuals stimulated with parasite antigen following IL-27 or IL-37 neutralization. We also examined the production of prototypical type 1, type 2, type 9, type 17, and type 22 cytokines in the whole-blood supernatants. Our data reveal that IL-27 or IL-37 neutralization resulted in significantly enhanced frequencies of Th1/Tc1, Th2/Tc2, Th17/Tc17, Th9, and Th22 cells with parasite antigen stimulation. There was no induction of any T cell response in uninfected individuals following parasite antigen stimulation and IL-27 or IL-37 neutralization. Moreover, we also observed increased production of gamma interferon (IFN-γ), IL-5, IL-9, IL-17, and IL-22 and decreased production of IL-10 following IL-27 and IL-37 neutralization and parasite antigen stimulation in whole-blood cultures. Thus, we demonstrate that IL-27 and IL-37 limit the induction of particular T cell subsets along with cytokine responses in S. stercoralis infections, which suggest the importance of IL-27 and IL-37 in immune modulation in a chronic helminth infection.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  T cells; cytokines; helminths; immune mechanisms

Mesh:

Substances:

Year:  2017        PMID: 28874444      PMCID: PMC5649007          DOI: 10.1128/IAI.00500-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  The IL-27 receptor (WSX-1) is an inhibitor of innate and adaptive elements of type 2 immunity.

Authors:  David Artis; Alejandro Villarino; Michael Silverman; Weimian He; Elizabeth M Thornton; Sharon Mu; Shamin Summer; Todd M Covey; Elaine Huang; Hiroki Yoshida; Gary Koretzky; Michael Goldschmidt; Gary D Wu; Fred de Sauvage; Hugh R P Miller; Christiaan J M Saris; Phillip Scott; Christopher A Hunter
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

2.  Disruption of interleukin-27 signaling results in impaired gamma interferon production but does not significantly affect immunopathology in murine schistosome infection.

Authors:  Mara G Shainheit; Rosita Saraceno; Lindsey E Bazzone; Laura I Rutitzky; Miguel J Stadecker
Journal:  Infect Immun       Date:  2007-04-02       Impact factor: 3.441

3.  Parasite Antigen-Specific Regulation of Th1, Th2, and Th17 Responses in Strongyloides stercoralis Infection.

Authors:  Rajamanickam Anuradha; Saravanan Munisankar; Chandrakumar Dolla; Paul Kumaran; Thomas B Nutman; Subash Babu
Journal:  J Immunol       Date:  2015-07-22       Impact factor: 5.422

Review 4.  Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27.

Authors:  Caroline Pot; Lionel Apetoh; Amit Awasthi; Vijay K Kuchroo
Journal:  Semin Immunol       Date:  2011-09-03       Impact factor: 11.130

Review 5.  Interleukin-27: balancing protective and pathological immunity.

Authors:  Christopher A Hunter; Rob Kastelein
Journal:  Immunity       Date:  2012-12-14       Impact factor: 31.745

6.  Systemic Cytokine Profiles in Strongyloides stercoralis Infection and Alterations following Treatment.

Authors:  Rajamanickam Anuradha; Saravanan Munisankar; Yukti Bhootra; Jeeva Jagannathan; Chandrakumar Dolla; Paul Kumaran; Kui Shen; Thomas B Nutman; Subash Babu
Journal:  Infect Immun       Date:  2015-11-23       Impact factor: 3.441

Review 7.  Human infection with Strongyloides stercoralis and other related Strongyloides species.

Authors:  Thomas B Nutman
Journal:  Parasitology       Date:  2016-05-16       Impact factor: 3.234

Review 8.  Advances in understanding the anti-inflammatory properties of IL-27.

Authors:  J S Stumhofer; C A Hunter
Journal:  Immunol Lett       Date:  2008-03-03       Impact factor: 3.685

9.  IL-37 is a fundamental inhibitor of innate immunity.

Authors:  Marcel F Nold; Claudia A Nold-Petry; Jarod A Zepp; Brent E Palmer; Philip Bufler; Charles A Dinarello
Journal:  Nat Immunol       Date:  2010-10-10       Impact factor: 25.606

Review 10.  From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines.

Authors:  Jacques Banchereau; Virginia Pascual; Anne O'Garra
Journal:  Nat Immunol       Date:  2012-09-18       Impact factor: 25.606

View more
  3 in total

1.  IL-27 Enhances γδ T Cell-Mediated Innate Resistance to Primary Hookworm Infection in the Lungs.

Authors:  Arjun Sharma; Jason B Noon; Konstantinos Kontodimas; Lucien P Garo; Johannes Platten; Lee J Quinton; Joseph F Urban; Christoph Reinhardt; Markus Bosmann
Journal:  J Immunol       Date:  2022-03-30       Impact factor: 5.426

2.  Systemic Cytokine and Chemokine Profiles in Individuals With Schistosoma mansoni Infection and Low Parasite Burden.

Authors:  Vanessa N Castro; Jailza L Rodrigues; Diogo T Cardoso; Samira D Resende; Fernanda C Magalhães; Dayane C Souza; Maira H Requeijo; Deborah Negrão-Corrêa; Stefan M Geiger
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

3.  IL-27 Derived From Macrophages Facilitates IL-15 Production and T Cell Maintenance Following Allergic Hypersensitivity Responses.

Authors:  Jutamas Suwanpradid; Min Jin Lee; Peter Hoang; Jeffery Kwock; Lauren P Floyd; Jeffrey S Smith; Zhinan Yin; Amber R Atwater; Sudarshan Rajagopal; Ross M Kedl; David L Corcoran; Jennifer Y Zhang; Amanda S MacLeod
Journal:  Front Immunol       Date:  2021-09-30       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.